Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of vintafolide (EC145/MK-8109) in patients with progressive lung adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Vintafolide (MK-8109 / EC145)

Snippet

Sponsor: Endocyte | Conditions: Adenocarcinoma of the Lung | Phase 2 | Status: COMPLETED